pentobarbital will lower the extent or impact of montelukast by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
Contraindicated (one)pentobarbital will minimize the level or influence of lorlatinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
Withdrawal indicators might happen from abrupt cessation just after prolonged use from the dependent particular person and could end in delirium, convulsions, And maybe Loss of life; barbiturates really should be withdrawn little by little from any affected person known being taking extreme dosage about extended amounts of time
pentobarbital will lower the extent or outcome of fosamprenavir by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
pentobarbital will minimize the level or outcome of fesoterodine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
pentobarbital will decrease the extent or impact of carbamazepine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
pentobarbital will minimize the level or impact of glecaprevir/pibrentasvir by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will reduce the extent or outcome of dapsone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Mysterious.
pentobarbital will minimize the extent or impact of nimodipine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unknown.
pentobarbital will minimize the level or result of fosaprepitant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
pentobarbital will minimize the level or result of sulfamethoxazole by affecting hepatic enzyme CYP2C9/10 metabolism. Slight/Importance Unfamiliar.
pentobarbital will decrease the extent or effect of donepezil by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Mysterious.
buprenorphine subdermal implant click here and pentobarbital each maximize sedation. Keep away from or Use Alternate Drug. Restrict use to individuals for whom choice therapy solutions are inadequate
pentobarbital will decrease the level or outcome of disopyramide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Unfamiliar.